Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BloomWell Rx vs Ivy Rx

BloomWell Rx
Graded #298

Lower grade

vs+5.200000000000003
Ivy Rx
Graded #190

Higher grade

The verdict

Ivy Rx takes it — 66.5/100 to 61.3/100.

Ivy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIvy Rx +7
54
61
Dose & formulationEven
64
64
Clinical oversightIvy Rx +11
71
82
Labs & monitoringEven
53
53
FulfillmentIvy Rx +11
70
81
Contract termsEven
55
55
BloomWell Rx · left barIvy Rx · right bar

The numbers

MetricBloomWell RxIvy Rx
WeighScore61.3/10066.5/100
GradeCC
Scorecard rank#298#190
Semaglutide$199/mo (starting dose, compounded)$175/mo (starting dose, compounded)
Tirzepatide$249/mo (starting dose, compounded)$275/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
BloomWell Rx

Graded #298 · C

Strengths

  • Transparent pricing — compounded semaglutide from $199/mo, tirzepatide (GLP-1/GIP) from $249/mo
  • Free initial visit; fully online process with flexible dosing options
  • Discloses meds are compounded by a licensed third-party pharmacy; also offers NAD+, sermorelin, glutathione
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)

Where it loses points

  • 'Starts at' pricing — final cost depends on dose and plan
  • Compounding pharmacy partner not named ('licensed third-party pharmacy')
  • Not LegitScript-certified (no certification displayed)
  • Operating medical entity not clearly named (site operated by a marketing agency)
Ivy Rx

Graded #190 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard